On March 30, ADVI Health’s Ashis Das was featured in Endpoints News, sharing insight on shifting expectations in evidence policy.

In the article, “CMS is quietly pivoting to real-world evidence in next IRA phase,” Ashis discusses the Inflation Reduction Act’s new era of evidence-based Medicare drug pricing.

Read the full article in Endpoints News.